Sirenia Capital Management LP 13D/13G Filings for Xilio Therapeutics, Inc. (XLO)

Sirenia Capital Management LP 13D and 13G filings for Xilio Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
08:06 am
Purchase
2026-03-3113GXILIO THERAPEUTICS INC
XLO
Sirenia Capital Management LP1,142,862
9.900%
1,142,862increase
(New Position)
Filing